May 4, 2026

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 26% Upside Potential in the Healthcare Sector

For investors keeping an eye on the healthcare sector, Intuitive Surgical, Inc. (NASDAQ: ISRG) presents a compelling opportunity. With a market capitalization of $162.13 billion, this leader in medical instruments..

Merit Medical Systems, Inc. (MMSI): Investor Outlook on a Potential 46% Upside

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leader in the healthcare sector specializing in the design and production of single-use medical products, presents a compelling investment opportunity with a potential..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a Potential 18.85% Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the healthcare sector specializing in medical devices, presents a compelling case for investors seeking exposure to the orthopedic and reconstructive..

Stryker Corporation (SYK) Stock Analysis: Unpacking a 33.72% Potential Upside for Investors

Investors with an eye on the healthcare sector would do well to consider Stryker Corporation (NYSE: SYK), a leading player in the medical devices industry with a market capitalization of..

Solventum Corporation (SOLV) Stock Analysis: Unraveling a 26% Upside Potential in the Healthcare Sector

Solventum Corporation (NYSE: SOLV), a prominent player in the healthcare sector, is drawing attention from investors with its robust presence in the medical instruments and supplies industry. Headquartered in Eagan,..

BridgeBio Pharma (BBIO) Stock Analysis: Exploring a 47.59% Potential Upside in the Biotech Sector

BridgeBio Pharma, Inc. (NASDAQ: BBIO) stands at the forefront of the biotechnology industry, captivating investor attention with its innovative approach to treating genetic diseases. With a staggering market capitalization of..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Uncovering a Potential 40.88% Upside in the Healthcare Sector

Neurocrine Biosciences, Inc. (NBIX) stands out as a promising player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a robust market capitalization of $13.25..

IDEXX Laboratories (IDXX) Investor Outlook: Unpacking a 27.67% Upside Potential

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare sector specializing in diagnostics and research, is capturing the attention of investors with its impressive market presence and growth..

Repligen Corporation (RGEN): Analyst Consensus Highlights Strong Buy Ratings and 53% Potential Upside

For investors with a keen eye on the healthcare sector, Repligen Corporation (NASDAQ: RGEN) presents a compelling case. With a market capitalization of $6.61 billion, this U.S.-based life sciences company..

Danaher Corporation (DHR) Stock Analysis: Promising 42.81% Upside According to Analysts

Danaher Corporation (NYSE: DHR), a prominent player in the healthcare sector, stands poised for a potential upswing. With a market capitalization of $123.97 billion, Danaher operates in the diagnostics and..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Navigating a 51.79% Potential Upside in the Biotech Sector

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) presents an intriguing opportunity for investors with a knack for biotechnology stocks. With a market capitalization of $39.51 billion, this U.S.-based biopharmaceutical company is at..

Genmab A/S (GMAB) Stock Analysis: Exploring a 41.59% Potential Upside in the Biotech Sector

Genmab A/S (NASDAQ: GMAB), a prominent biotechnology company headquartered in Copenhagen, Denmark, is generating significant interest among investors, particularly due to its robust potential upside of 41.59%. As a key..

ICON plc (ICLR)

⚠️ No article content returned.

..

Globus Medical, Inc. (GMED) Stock Report: A 20.52% Upside Potential in the Medical Devices Sector

Globus Medical, Inc. (NYSE: GMED), a key player in the healthcare sector specializing in medical devices, is catching the attention of investors with its impressive growth trajectory and promising market..

Regeneron Pharmaceuticals, Inc. (REGN)

⚠️ No article content returned.

..

CVS Health Corporation (CVS) Stock Analysis: A Promising 17.65% Upside Amid Robust Sector Positioning

Investor interest in CVS Health Corporation (NYSE: CVS) is on the rise as the healthcare giant navigates the evolving landscape of healthcare services with strategic precision. With a market capitalization..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A 45% Potential Upside Awaits Investors

IQVIA Holdings, Inc. (NYSE: IQV), a prominent player in the healthcare sector specializing in diagnostics and research, is capturing the attention of investors with its robust growth potential and compelling..

Abbott Laboratories (ABT) Stock Analysis: Navigating a Potential 32.62% Upside with Solid Dividends

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector with a focus on medical devices, presents a compelling opportunity for investors seeking stability paired with growth potential. With a..

West Pharmaceutical Services (WST): An In-Depth Stock Analysis Reveals 16.35% Potential Upside

As healthcare continues to be a focal point of global investment, West Pharmaceutical Services, Inc. (NYSE: WST) stands out as a robust player in the Medical Instruments & Supplies industry...

Tempus AI, Inc. (TEM) Stock Analysis: Navigating a 31.61% Potential Upside in the Healthcare Tech Market

Tempus AI, Inc. (TEM) is carving out a distinctive niche within the healthcare technology sector by harnessing advanced AI capabilities to drive innovation in health information services. Based in Chicago..

Search

Funds

May 4, 2026

Search

Funds

May 4, 2026

FTSE 100

Funds